Abstract
Objective
At our institutions, mitral valve vegetation with a high risk for embolism is surgically treated as soon as possible to maintain the quality of life of patients, and valve repair has been actively performed. We reviewed the surgical outcome for active mitral infective endocarditis (AMIE) following this treatment policy.
Methods
Fifty-seven patients underwent surgery for native AMIE between April 1999 and December 2012 (repair 36, replacement 21). We retrospectively investigated the risk factors for in-hospital death, the prognosis of patients with cerebral infarction, and the short- and long-term outcomes of valve repair and replacement.
Results
The preoperative conditions and the intraoperative findings in the replacement group were more complicated. But, no significant differences were observed in in-hospital mortality, 4-year survival, or 4-year reoperation-free rate between the groups (repair 8, 88.2, and 92.4 %; replacement 9, 90.5, and 94.7 %, respectively). The incidence of postoperative cardiac-related events including heart failure, thromboembolism, and major bleeding was higher in the replacement group. Although our study failed to identify predictors of in-hospital mortality, uncontrolled and nosocomial infections were responsible for high in-hospital mortality of 17 and 33 %, respectively. Nine patients with symptomatic non-hemorrhagic cerebral infarction underwent early surgery within 2 weeks of the onset of stroke (median maximum infarct diameter and volume: 18.2 mm and 0.72 cm3, respectively). No patients had severe hemorrhagic conversion.
Conclusion
Mitral valve repair is appropriate to prevent postoperative cardiac-related events. Reducing in-hospital mortality due to uncontrolled infection remains challenging. Early surgery may be reasonable for patients with small non-hemorrhagic infarction.
Similar content being viewed by others
References
Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009). Eur Heart J. 2009;30:2369–413.
Bonow RO, Carabello BA, Chatterjee K, De Leon AC Jr, Faxon DP, Freed MD, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol. 2008;52:e1–142.
Dreyfus G, Serraf A, Jebara VA, Deloche A, Chauvaud S, Couetil JP, et al. Valve repair in acute endocarditis. Ann Thorac Surg. 1990;49:706–11.
Muehrcke DD, Cosgrove DM 3rd, Lytle BW, Taylor PC, Burgar AM, Durnwald CP, et al. Is there an advantage to repairing infected mitral valves? Ann Thorac Surg. 1997;63:1718–24.
Lee EM, Shapiro LM, Wells FC. Conservative operation for infective endocarditis of the mitral valve. Ann Thorac Surg. 1998;65:1087–92.
Podesser BK, Rödler S, Hahn R, Eigenbauer E, Vodrazka M, Moritz A, et al. Mid-term follow up of mitral valve reconstruction due to active infective endocarditis. J Heart Valve Dis. 2000;9:335–40.
Senni M, Merlo M, Sangiorgi G, Gamba A, Procopio A, Glauber M, et al. Mitral valve repair and transesophageal echocardiographic findings in a high-risk subgroup of patients with active, acute infective endocarditis. J Heart Valve Dis. 2001;10:72–7.
Sternik L, Zehr KJ, Orszulak TA, Mullany CJ, Daly RC, Schaff HV. The advantage of repair of mitral valve in acute endocarditis. J Heart Valve Dis. 2002;11:91–7.
Mihaljevic T, Paul S, Leacche M, Rawn JD, Aranki S, O’Gara PT, et al. Tailored surgical therapy for acute native mitral valve endocarditis. J Heart Valve Dis. 2004;13:210–6.
Iung B, Rousseau-Paziaud J, Cormier B, Garbarz E, Fondard O, Brochet E, et al. Contemporary results of mitral valve repair for infective endocarditis. J Am Coll Cardiol. 2004;43:386–92.
Ruttmann E, Legit C, Poelzl G, Mueller S, Chevtchik O, Cottogni M, et al. Mitral valve repair provides improved outcome over replacement in active infective endocarditis. J Thorac Cardiovasc Surg. 2005;130:765–71.
Zegdi R, Debièche M, Latrémouille C, Lebied D, Chardigny C, Grinda JM, et al. Long-term results of mitral valve repair in active endocarditis. Circulation. 2005;111:2532–6.
Doukas G, Oc M, Alexiou C, Sosnowski AW, Samani NJ, Spyt TJ. Mitral valve repair for active culture positive infective endocarditis. Heart. 2006;92:361–3.
Shang E, Forrest GN, Chizmar T, Chim J, Brown JM, Zhan M, et al. Mitral valve infective endocarditis: benefit of early operation and aggressive use of repair. Ann Thorac Surg. 2009;88:1728–33.
Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012;366:2466–73.
Yamaguchi H, Eishi K, Yamachika S, Hisata Y, Tanigawa K, Izumi K, et al. Mitral valve repair in patients with infective endocarditis. Circ J. 2006;70:179–83.
Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994;96:200–9.
Manhas DR, Mohri H, Hessel EA 2nd, Merendino KA. Experience with surgical management of primary infective endocarditis: a collected review of 139 patients. Am Heart J. 1972;84:738–47.
Akins CW, Miller DC, Turina MI, Kouchoukos NT, Blackstone EH, Grunkemeier GL, et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg. 2008;135:732–8.
Feringa HH, Shaw LJ, Poldermans D, Hoeks S, van der Wall EE, Dion RA, et al. Mitral valve repair and replacement in endocarditis: a systematic review of literature. Ann Thorac Surg. 2007;83:564–70.
Shomura Y, Okada Y, Masu M, Koyama T, Yuzaki M, Murashita T, et al. Late results of mitral valve repair with glutaraldehyde-treated autologous pericardium. Ann Thorac Surg. 2013;95:2000–5.
Cooper HA, Thompson EC, Laureno R, Fuisz A, Mark AS, Lin M, et al. Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses (EMBOLISM) pilot study. Circulation. 2009;120:585–91.
Thuny F, Avierinos JF, Tribouilloy C, Giorgi R, Casalta JP, Milandre L, et al. Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicenter study. Eur Heart J. 2007;28:1155–61.
Snygg-Martin U, Gustafsson L, Rosengren L, Alsiö A, Ackerholm P, Andersson R, et al. Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis. 2008;47:23–30.
Hosono M, Sasaki Y, Hirai H, Sakaguchi M, Nakahira A, Seo H, et al. Considerations in timing of surgical intervention for infective endocarditis with cerebrovascular complications. J Heart Valve Dis. 2010;19:321–5.
Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Höfer D, Poewe W, et al. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke. 2006;37:2094–9.
Yoshioka D, Sakaguchi T, Yamauchi T, Okazaki S, Miyagawa S, Nishi H, et al. Impact of early surgical treatment on postoperative neurologic outcome for active infective endocarditis complicated by cerebral infarction. Ann Thorac Surg. 2012;94:489–95.
Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan. J Thorac Cardiovasc Surg. 1995;110:1745–55.
Okada Y, Hosono M, Sasaki Y, Hirai H, Suehiro S. Preoperative increasing C-reactive protein affects the outcome for active infective endocarditis. Ann Thorac Cardiovasc Surg. 2013 [Epub ahead of print].
Shibata T, Sasaki Y, Hirai H, Fukui T, Hosono M, Suehiro S. Early surgery for hospital-acquired and community-acquired active infective endocarditis. Interact Cardiovasc Thorac Surg. 2007;6:354–7.
Acknowledgments
We are grateful to Dr. Yohei Tateishi, Department of Neurology, Nagasaki University Hospital, for his cooperation in the treatment of infective endocarditis patients with brain complications, and express special thanks to Dr. Seiji Matsukuma and Dr. Ichiro Matsumaru for providing the valuable data.
Conflict of interest
The authors report no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miura, T., Hamawaki, M., Hazama, S. et al. Outcome of surgical management for active mitral native valve infective endocarditis: a collective review of 57 patients. Gen Thorac Cardiovasc Surg 62, 488–498 (2014). https://doi.org/10.1007/s11748-014-0377-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-014-0377-y